An Open-Label Crossover Study To Evaluate Potential Pharmacokinetic Interactions between Oral Oseltamivir and Intravenous Zanamivir in Healthy Thai Adults

There is no parenteral formulation of the neuraminidase inhibitor oseltamivir, the most widely used anti-influenza virus drug. Oseltamivir resistance is an increasing problem. Zanamivir is effective against the most prevalent oseltamivir-resistant influenza viruses. A parenteral formulation of zanam...

Full description

Saved in:
Bibliographic Details
Main Authors: Pukrittayakamee, Sasithon, Jittamala, Podjanee, Stepniewska, Kasia, Lindegardh, Niklas, Chueasuwanchai, Sunee, Leowattana, Wattana, Phakdeeraj, Aphiradee, Permpunpanich, Sutatip, Hanpithakpong, Warunee, Pan-Ngum, Wirichada, Fukuda, Caroline, Panapipat, Salwaluk, Singhasivanon, Pratap, White, Nicholas J., Day, Nicholas P. J.
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2011
Subjects:
Antiviral Agents
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3165358/
https://ncbi.nlm.nih.gov/pubmed/21690287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00159-11
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items